Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
03/1998
03/11/1998CN1037682C Process for preparing 2 -hydroxymethyl -5 -(5 -fluorocytosin -1 -yl) -1 ,3 -oxathiolane
03/05/1998WO1998008525A1 Process to obtain oestrogens from mare's urine
03/05/1998WO1998008520A1 Treatment of pain
03/05/1998WO1998008488A2 Cold cream cosmetic composition
03/04/1998EP0826372A2 Process of preparation of a stable, homogeneous, free or quite free of impurities extract
03/04/1998EP0758963B1 Positioning device for a mobile phone
03/04/1998EP0676956B1 A method for preparing pharmaceutical compositions through ultrasonic means
03/04/1998EP0616523B1 Medicaments
03/04/1998CN1175259A Low molecular weight bicyclic thrombin inhibitors
03/04/1998CN1175254A Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
03/04/1998CN1175212A Use of aminopurine antiviral agents for the thratment and prophylaxis of latent herpesvirus infections
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723146 Pharmaceutical preparations
02/1998
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007432A1 Beta2 integrin cell adhesion molecule inhibitors
02/26/1998WO1998007417A1 Pharmaceutical composition comprising coenzyme q¿10?
02/26/1998WO1997044007A3 A barrier cream comprising hexamethylenetetramine or derivative thereof
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824588A1 Il-6 activity inhibitor
02/25/1998CN1174511A In-vivo diagnostic process by near infrared radiation
02/25/1998CN1037510C Prep. of indole derivatives
02/24/1998US5721245 4- 3-indolyl!-1H-pyrrolone
02/19/1998WO1998006418A1 Compositions of plant carbohydrates as dietary supplements
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/18/1998CN1173324A Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and uses thereof
02/12/1998WO1998005364A2 Improvements in or relating to contrast agents
02/12/1998WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them
02/12/1998WO1998005302A1 Aerosol formulations
02/12/1998DE19652183C1 Treating oestrogen-dependent tumour with Cimicifuga racemosa extract
02/12/1998CA2262908A1 Contrast agents for ultrasound imaging of the liver
02/11/1998EP0822820A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
02/11/1998CN1173132A Dihydropyrimidines and uses thereof
02/11/1998CN1172591A Dietetic foods and pharmaceutical preparations inhibiting blood coagulation
02/10/1998US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy
02/10/1998US5716973 Anti-viral compounds
02/10/1998US5716918 Sulfonate perfumes for dryer-activated fabric conditioning and antistatic compositions
02/10/1998US5716817 Dna molecule containing intron sequence; bile salt stimulated lipase or carboxy ester lipase
02/10/1998US5716777 Regulation of meiosis using sterols
02/10/1998CA2116234C Use of n-acetyl-l-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
02/10/1998CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis
02/04/1998EP0822178A1 New rhein derivatives and new processes for producing rhein derivatives
02/04/1998EP0821728A1 Tie-2 ligands, methods of making and uses thereof
02/04/1998EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
02/04/1998CN1171935A Gel cleanser composition
02/04/1998CN1037235C Use of 6-(substituted amino) purine cytokinin in preparation of antisenlity composition
02/03/1998US5714520 Propofol compostion containing edetate
02/03/1998US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example
02/03/1998US5714166 Bioactive and/or targeted dendrimer conjugates
01/1998
01/29/1998WO1998003510A1 Azolo triazines and pyrimidines
01/29/1998WO1998003196A1 Intradermal bovine polynucleotide vaccine
01/29/1998WO1998003146A1 Use of novel glass compositions in preparing dental glass pillars and support pillars, and method for producing the glass pillars
01/29/1998CA2261055A1 Use of novel glass compositions in preparing dental glass pillars and support pillars, and method for producing the glass pillars
01/27/1998US5711933 Method of making polymeric gas or air filled microballoons for ultrasonic echography
01/27/1998CA2194564C Aqueous risperidone formulations
01/22/1998WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/21/1998EP0504363B1 PURIFIED IgG ANTIBODIES
01/20/1998US5710294 Treatment of malignant and other diseases characterized by proliferative growth of undifferentiated cells
01/20/1998US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases
01/20/1998US5709881 Tablet capsule or granule comprising desogestrel
01/20/1998CA2093653C Cleansing compositions
01/14/1998EP0817775A1 Quinazoline derivatives
01/14/1998EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
01/14/1998EP0817634A1 Azathioprine compositions for colonic administration
01/14/1998EP0817608A1 Liquid cleanser compositions
01/14/1998CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression
01/14/1998CN1170356A Aerosol drug formulations
01/13/1998US5707646 Complex formed by dispersion of drug with eudragit? and polyvinylacetal diethylaminoacetate and sugar alcohol with basic oxide
01/13/1998US5707615 Method of treating HIV infections with anti-viral formulations
01/08/1998WO1997041824A3 Antiangiogenic peptides derived from plasminogen
01/08/1998WO1997031620A3 Topical compositions comprising an oil-in-water emulsion and a retinoid
01/07/1998EP0815852A1 A method for high loading of vesicles with biopolymeric substances
01/07/1998EP0815831A1 Dentifrice composition
01/07/1998EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8
01/07/1998EP0814789A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
01/07/1998EP0814787A1 Oil in water emulsions containing propofol and edetate
01/07/1998EP0814757A2 Anhydrous delivery vehicle for cosmetic ingredients
01/07/1998EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease
01/06/1998US5705489 Having antithrombotic activity
12/1997
12/31/1997WO1997049408A1 The use of growth factor modulating compounds
12/30/1997CA2085231C Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
12/29/1997EP0813416A1 Reduction of infarct volume using citicoline
12/29/1997EP0523109B1 Hair styling shampoos
12/24/1997WO1997048410A1 Cyclosporin-containing soft capsule preparations
12/24/1997WO1997048401A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
12/24/1997WO1997042963A3 Green ointment
12/24/1997CA2258202A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
12/23/1997US5700448 Contrast media
12/18/1997WO1997047273A1 Antiperspirant composition
12/18/1997WO1997047171A1 Skin wash composition
12/17/1997EP0812184A1 Nitric oxide synthase inhibitors
12/17/1997EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
12/17/1997EP0591311B1 Controlled release systems and low dose androgens
12/17/1997CN1167752A Novel retinoids derivs.
12/16/1997US5698690 Hydroxamic acid derivatives with tricyclic substitution
12/16/1997US5698595 Use of sulfonic acids as anti-ageing agents in a cosmetic or dermatological composition